Table.
Loading group (n=34) | Non-loading group (n=61) | p value | |
---|---|---|---|
Age, years | 71.8±13.3 | 71.7±11.2 | 0.958 |
Female sex, no. (%) | 13 (38) | 29 (48) | 0.399 |
Hypertension, no. (%) | 22 (65) | 50 (82) | 0.081 |
Diabetes mellitus, no. (%) | 9 (26) | 23 (38) | 0.366 |
Hyperlipidemia, no. (%) | 16 (47) | 29 (48) | 1.000 |
Coronary heart disease, no. (%) | 4 (12) | 6 (10) | 0.742 |
Cerebral infarction, no. (%) | 5 (15) | 6 (10) | 0.515 |
Smoking history, no. (%) | 6 (18) | 14 (23) | 0.609 |
Systolic blood pressure, mmHg | 180.9±30.9 | 191.3±30.8 | 0.118 |
Diastolic blood pressure, mmHg | 97.7±16.6 | 95.4±21.3 | 0.584 |
BW, kg | 61.8±13.9 | 58.7±11.8 | 0.261 |
Glucose level, mg/dL | 135.9±70.3 | 144.8±77.8 | 0.582 |
Hemoglobin A1c, % | 6.1±1.6 | 6.4±1.7 | 0.315 |
Creatinine, mg/dL | 1.07±1.43 | 0.85±0.60 | 0.283 |
Creatinine clearance, mL/min | 72.6±37.4 | 73.7±31.2 | 0.879 |
Triglyceride, mg/dL | 116.0±50.3 | 130.0±74.3 | 0.268 |
Total cholesterol, mg/dL | 208.0±49.7 | 219.0±51.7 | 0.462 |
Low-density lipoprotein cholesterol, mg/dL | 144.0±40.1 | 139.0±42.8 | 0.581 |
NIHSS score on admission | 2.5 (2-4) | 3 (2-4) | 0.771 |
Infarct volume, mL | 1.08±1.71 | 0.91±1.06 | 0.548 |
Treatment with antithrombotic drugs on admission | 5 (18) | 7 (11) | 0.750 |
Aspirin | 2 | 4 | |
Clopidogrel | 2 | 3 | |
Cilostazol | 1 | ||
Concomitant medication | |||
Statin, no. (%) | 27 (79) | 39 (64) | 0.163 |
Edaravone, no. (%) | 30 (88) | 55 (90) | 0.742 |
Duration of hospitalization, days | 17.5 (14.25-28) | 19 (12-29) | 0.855 |
Data are shown as mean±SD, median (interquartile range), or number (%). BA: basilar artery, BMI: body mass index, BW: body weight, DWI-ASPECTS: Alberta stroke program early computed tomography score on diffusion-weighted imaging, ICA: internal carotid artery, MCA: middle cerebral artery, NIHSS: National Institutes of Health Stroke Scale, rt-PA: recombinant tissue plasminogen activator